Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

One-Year Results of GENOSS PCB (Paclitaxel-coated Balloon With a Shellac Plus Vitamin E Excipient) Real-World Study in Femoropopliteal Artery Disease: A Prospective, Multicenter, Observational Study (GENOSS PCB-F/P)

NCT07431437 is registered in ClinicalTrials.gov with Genoss Co., Ltd. as lead sponsor.

NCT NCT07431437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07431437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
One-Year Results of GENOSS PCB (Paclitaxel-coated Balloon With a Shellac Plus Vitamin E Excipient) Real-World Study in Femoropopliteal Artery Disease: A Prospective, Multicenter, Observational Study (GENOSS PCB-F/P)
Lead sponsor
Genoss Co., Ltd.
Phase
Observational
Overall status
Enrolling by invitation
Start date
June 17, 2025
Completion date
June 30, 2028
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

femoropopliteal artery disease, pta (percutaneous transluminal angioplasty)